ClinVar Miner

Submissions for variant NR_023343.1(RNU4ATAC):n.48G>A (rs863225422)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Undiagnosed Diseases Network,NIH RCV000202314 SCV000837726 likely pathogenic Roifman syndrome 2018-03-20 criteria provided, single submitter clinical testing
Illumina Clinical Services Laboratory,Illumina RCV001095783 SCV001251631 likely pathogenic RNU4ATAC-related spliceosomopathies 2020-01-31 criteria provided, single submitter clinical testing The RNU4ATAC n.48G>A variant is a single nucleotide variant in a non-coding region which impacts the U4atac snRNA. The n.48G>A variant is reported in a compound heterozygous state in one individual with Roifman syndrome (Merico et al. 2015). Additionally, the n.48G>A variant is reported in a compound heterozygous state in a second individual with Roifman syndrome in a submission from the Undiagnosed Disease Network (UDN) to the ClinVar database (Landrum et al. 2018). Although not described in the published literature, additional information about this child is available on the UDN website ( ). In both available cases, the n.48G>A variant was reported in trans with the n.13C>T variant. The n.48G>A variant is reported at a frequency of 0.000060 in the European (non-Finnish) population of the Genome Aggregation Database in a region of good sequence coverage so the variant is presumed to be rare. It is located in the kink-turn motif of the 5' stem loop of U4atac snRNA, which interacts with the human NHP2L1 protein during assembly of the minor spliceosome. While the consequences of the n.48G>A variant have not been evaluated experimentally, other variants in the kink-turn motif of the 5' stem loop and observed in individuals with Taybi Linder syndrome have been shown to impair binding to the NHP2L1 protein and minor spliceosome function (Jafarifar et al. 2014; Merico et al. 2015). Based on the collective evidence, the n.48G>A variant is classified as likely pathogenic for RNU4ATAC-related spliceosomopathies.
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV001268112 SCV001446769 likely pathogenic not provided 2020-10-23 criteria provided, single submitter clinical testing
OMIM RCV000202314 SCV000257316 pathogenic Roifman syndrome 2015-11-02 no assertion criteria provided literature only
Service de Génétique Moléculaire,Hôpital Robert Debré RCV001255778 SCV001432378 likely pathogenic Osteodysplastic primordial dwarfism, type 1 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.